Barbara Balser

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

Bertrand Coiffier, Barbara Pro, H. Miles Prince et al. · Journal of Clinical Oncology · 2012 · 674 citations

Medicine, Pharmacology, Pharmacotherapy +13

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

Bertrand Coiffier, Barbara Pro, H. Miles Prince et al. · Journal of Hematology & Oncology · 2014 · 209 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach

Robert Kueffner, Neta Zach, Maya Bronfeld et al. · Scientific Reports · 2019 · 56 citations · Full text

Computing, Data Science, Neurology +17

Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

Francine M. Foss, Barbara Pro, H. Miles Prince et al. · Journal of Hematology & Oncology · 2016 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Electrocardiographic effects of class 1 selective histone deacetylase inhibitor romidepsin

Philip T. Sager, Barbara Balser, Julie Wolfson et al. · Cancer Medicine · 2015 · 40 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11